Park Square has placed Mireli Fino as Executive Vice Chancellor for MassBiologics at the University of Massachusetts Medical School.
As the nation’s only nonprofit FDA-licensed manufacturer of vaccines and biologics, MassBiologics is a special part of UMass Medical School, one with unique potential to improve the health of people around the globe. With this special mission in mind, Chancellor Michael F. Collins announced that Mireli Fino, MBA, will be the next executive vice chancellor for MassBiologics, beginning in July.